The roles of lipid metabolism in the maintenance of hematopoietic stem cells
Project Number6R01DK098263-08
Contact PI/Project LeaderITO, KEISUKE
Awardee OrganizationALBERT EINSTEIN COLLEGE OF MEDICINE
Description
Abstract Text
ABSTRACT
The symmetry of stem cell division is one of the most fundamental questions in stem cell biology, and a leading
goal of our research is identification of the key metabolic pathways that regulate hematopoietic stem cell (HSC)
fate. We hypothesize that lipid metabolism contributes to HSC maintenance through precise control of division
patterns. Single-cell approaches have identified the enhanced clearance of damaged mitochondria by fatty acid
oxidation as an important mechanism of the self-renewing expansion of HSCs. However, our understanding of
the relationship between HSC self-renewal and lipid metabolism is limited, as analyses of individual HSC division
patterns have been hindered by both the heterogeneity of available HSC-enriched fractions and the technical
challenges of imaging HSC fate in vivo. In addition, the number of cells required for full metabolomics analysis
of rare populations of HSCs has proven prohibitive. To examine the activity upstream of fatty acid oxidation in
HSCs, we have generated hematopoietic-specific conditional knockout mice for key genes impacting fatty acid
oxidation pathway and/or fatty acid flow. A new biosensor for assessment of fatty acid oxidation activity in live
cells has likewise been established to determine the metabolic modes which are most relevant to the controlled
equilibrium of HSCs, and the gene-expression oriented bioinformatics tool, graphite, has been adapted to identify
specific metabolite-dependent pathways. In order to illuminate the behavior of individual HSCs in vivo, we have
established new technical regimens which include prospective isolation of HSCs with high purity based on Tie2
positivity, a local transplantation technique which delivers a single HSC under multiphoton microscopy guidance
into the bone marrow of a live mouse, and micropipette aspiration to extract single cells after division directly
from the bone marrow for functional or transcriptomic assay. Our project will utilize these advances to test our
hypothesis regarding the roles of lipid metabolism in HSC fate choice. This in turn will facilitate novel therapeutic
strategies for shifting the division balance of HSCs toward self-renewal through metabolic manipulation, and
possibly contribute to improved clinical outcomes after HSC transplantation for non-malignant blood diseases.
Thus, the goals of this proposal are three-fold: (1) In Aim 1, we will investigate the function of mitochondrial fatty
acid oxidation in HSC division symmetry and explore a potential source of fatty acids to fulfill the requirements
of HSCs; (2) In Aim 2, we will use the biosensor to identify key downstream metabolic targets of fatty acid
metabolism for HSC fate and explore the measurement of the cellular metabolome in HSCs; and (3) finally, we
propose in Aim 3 to directly examine in vivo HSC division symmetry, and the resulting division balance of fatty
acid oxidation-defective HSCs will show definitively the in vivo relevance of fatty acid metabolism to HSC fate. If
successful, the proposed research will positively impact the HSC field by providing a deeper understanding of
the metabolic cues governing HSC fate decisions.
Public Health Relevance Statement
PROJECT NARRATIVE
Hematopoietic stem cell (HSC) division results in either self-renewal or differentiation, with the balance between
the two options directly impacting hematopoietic homeostasis, but precisely how the specific modes of
metabolism controls HSC fates remains unclear. This project utilizes various genetic models and metabolic
assessments as well as single-cell approaches to understand the metabolic cues governing HSC fate decisions,
with a focus on lipid metabolism. The resulting insights into the metabolic requirements of cell division will have
a major impact on HSC research as well as current clinical practice for hematological diseases, as they will
identify new strategies for shifting the division balance of HSCs toward self-renewal through metabolic
manipulation.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
081266487
UEI
H6N1ZF5HJ2G3
Project Start Date
01-April-2013
Project End Date
31-March-2022
Budget Start Date
01-January-2019
Budget End Date
31-March-2019
Project Funding Information for 2018
Total Funding
$142,252
Direct Costs
$85,181
Indirect Costs
$57,071
Year
Funding IC
FY Total Cost by IC
2018
National Institute of Diabetes and Digestive and Kidney Diseases
$142,252
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 6R01DK098263-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 6R01DK098263-08
Patents
No Patents information available for 6R01DK098263-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 6R01DK098263-08
Clinical Studies
No Clinical Studies information available for 6R01DK098263-08
News and More
Related News Releases
No news release information available for 6R01DK098263-08
History
No Historical information available for 6R01DK098263-08
Similar Projects
No Similar Projects information available for 6R01DK098263-08